FDA promotes Bumpus to replace Woodcock—Chutes & Ladders fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.
The biotech focused on novel antibody therapies will now be called Spyre Therapeutics, as part of a rebrand to expand its inflammatory bowel disease pipeline.